The Shotlee Journal
Browse Shotlee articles about Weight Loss.
Showing 9 / 1248 Weight Loss articles
Marc McKee dropped nine stone with Mounjaro, transforming his health but leaving him with loose skin that inspired a new business. ElastiK Skin targets GLP-1 weight loss side effects using peptides, hyaluronic acid, and LED therapy. Early users report better hydration and elasticity with consistent use.
Stopping Ozempic often leads to weight regain—up to 7% in trials or two-thirds within a year. While continuing semaglutide helps sustain losses, lifestyle changes and maintenance dosing offer alternatives. Work with your healthcare team for a personalized plan to keep the weight off long-term.
Claudia Oshry is candid about restarting GLP-1 medications after welcoming son Reuben, calling it a 'relief' that helped her stay present during pregnancy and breastfeeding. The Toast host loves low-lift wellness like water, electrolytes, sun, and Dulcolax gummies for gut health. Now embracing her postpartum body, she blocks GLP-1 criticism amid life-changing results.
Ozempic has transformed weight loss by silencing 'food noise' for many users, but now 'Ozempic personality' is sparking debate. A report highlights mental health complaints during treatment. Is this side effect real, or just hype?
Authorities in India have seized more than 260 suspected fake Mounjaro pens, uncovering a counterfeit operation sourcing peptides from Alibaba and selling them cheaply on IndiaMART. The primary accused lacked a pharmaceutical license and produced them at a private property. This incident underscores growing risks in the booming obesity drug market as Mounjaro becomes India's top-seller.
While GLP-1R agonists like semaglutide (Wegovy) and tirzepatide (Zepbound) dominate the obesity market, non-GLP-1R targets are poised for explosive growth. Sales for these alternatives are expected to surge almost 50-fold from $310m in 2026 to $15.5bn in 2031, driven by calcitonin receptor drugs. This diversification signals a reshaping of the $172.6bn obesity pharmaceutical landscape by 2031.
Musician Adele transformed her body in 2020, losing 100 pounds via exercise and a healthy diet amid rising anxiety after her 2019 divorce. Before Ozempic and Mounjaro gained popularity, she focused on building physical and mental strength. Her before-and-after photos and candid interviews reveal a powerful story of self-improvement.
The surge in GLP-1 weight-loss injections like semaglutide in India, fueled by prices dropping up to 90%, is alarming doctors amid rising cosmetic misuse by young women. Social media and wedding pressures are pushing unsupervised use, risking serious side effects. Experts stress these are prescription therapies for obesity, not quick fixes.
Looksmaxxing started in incel circles but mirrors women's long history of extreme beauty pursuits, from plastic surgery to Ozempic weight loss. Radical tactics like bone-smashing and crystal meth highlight its dangers, while celebrity denials fuel uncanny reactions. Unpack the cultural shift pushing men into fraught body modification.
